TAVR Leads to ‘Beginning of a New Life’

Learn how this septuagenarian went from planning her funeral to dancing at her wedding, thanks to a procedure known as transcatheter aortic valve replacement, or TAVR.

7:00 AM

Author | Jane Racey Gleeson

Helen and her husband Ken Johnson at their wedding

Helen Turner faced her worst nightmare when doctors told her she wasn't a candidate for open-heart surgery to replace her failing bioprosthetic aortic valve.

"We think you'll die on the operating table," are the words she recalls.

"They gave me 18 months to live."

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Turner had undergone two open-heart surgeries: the first in 1995 to replace her aortic valve with a bioprosthetic (or tissue) valve due to aortic stenosis. Aortic stenosis is a condition in which the aortic valve does not open fully due to a thickening of the valve leaflets.

Helen and her grandson, William

Surgery allowed the avid exerciser with no history of heart disease to get back to enjoying life. But 16 years later, when she began to experience shortness of breath and exhaustion, tests showed her bioprosthetic valve had failed, requiring another open-heart surgery.

SEE ALSO: Weighing TAVR vs. SAVR for Aortic Stenosis Treatment

The need for a replacement valve was not a surprise.

Over the span of approximately 10 to 15 years, a bioprosthetic valve degenerates and eventually fails, requiring the need for a replacement. But some patients experience deterioration of their valves much earlier.

In Turner's case, her second bioprosthetic valve began to fail after only six years. This is when doctors said they could no longer help due to her worsening condition and two previous open-heart surgeries.

Planning her funeral

Turner, then 70, says she went home to plan her funeral.

But just months later, after seeking a second opinion from Michigan Medicine cardiac surgeon George Deeb, M.D., and interventional cardiologist Stanley Chetcuti, M.D., Turner was given new hope.

"I went from planning my funeral to dancing at my wedding," says the Warren, Michigan, resident and grandmother of William, 8, and Nicholas,12.

U-M's dedicated TAVR team determined that Turner was a candidate for a minimally invasive valve-in-valve transcatheter aortic valve replacement (TAVR) procedure to replace her failing bioprosthetic aortic valve.

Significant risk

While the standard treatment for aortic valve disease is open-heart surgery, repeat surgery carries significant risk, especially for older patients.

The TAVR procedure has proved to be a lifesaver for patients who aren't candidates for open-heart surgery, often due to multiple complications such as age, existing heart issues or prior open-heart surgeries.

Turner was such a patient.

"The TAVR team discussed her case and felt that with our experience and know-how with the valve-in-valve procedure we had a very good chance of a successful outcome," says Chetcuti. "She was all in and willing to fight."

But the surgery would not be without risk, including stroke, the possible need for a pacemaker and even death.

SEE ALSO: Minimally Invasive TAVR Stops a Life-Threatening Heart Condition

"With our great surgical team, expert support systems and extensive experience with the procedure, we were confident we could help this patient," says Chetcuti.   

TAVR is performed through small incisions that enable a new valve to be inserted into the patient through a catheter in the groin. During the valve-in-valve TAVR procedure, the new valve is placed through a catheter into the location of the failed bioprosthetic valve, pushing the old valve leaflets aside.

The less invasive valve-in-valve TAVR option is often the best choice for patients like Turner who previously underwent open-heart surgery for a tissue valve. TAVR is also being offered to patients at moderate risk for open surgery, with clinical trials currently being conducted for low-risk patients.

Dramatic improvements

The benefits of TAVR over open-heart surgery are significant: less down time, faster recovery and, often, a shorter hospital stay. TAVR patients also report dramatic improvements in their quality of life soon after the procedure.

Turner can attest to this.

Her TAVR in 2017 was performed on a Friday and she was released Sunday morning. Soon after, plans to marry her fiancé, Ken, were in full swing. Today, at 72, she's enjoying life as a newlywed and feeling like a new person.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

"We were extremely happy with the wonderful result in this patient," says Chetcuti. "When we saw her post-op, it was like seeing a new patient. Her heart function was 25 percent prior to the procedure and today it's 50 percent, which is the number we hope for."

Turner's perspective is equally optimistic: "This was a great end to my health issues and the beginning of a new life."

More Articles About: Heart Health Aortic Valve Disease Transcatheter Aortic Valve Replacement (TAVR) Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories
Health Lab
Is It Aortic Stenosis or Old Age? Symptoms to Know
Learn about aortic stenosis, including signs and symptoms, causes and treatments options, including SAVR and TAVR, from Michigan Medicine.
smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
heart organ yellow blue
Health Lab
Irregular heartbeat after valve surgery increases risk of stroke, death
Postoperative atrial fibrillation, commonly known as Afib, has traditionally been viewed as benign and limited. But a study led by researchers at the University of Michigan Health Frankel Cardiovascular Center finds that postoperative atrial fibrillation increases the risk of strokes and permanent Afib — and is linked to worse long term survival — after heart valve surgery.
human organ for transplant
Health Lab
Findings shed light on how a pediatric heart surgery complication impacts heart transplant survival
Patients who experience this condition following the Fontan continue to have a high risk of death from the time they’re waitlisted for a new heart through receiving the transplant, according to a 20-center study led by Michigan Medicine. And one specific complication called cyanosis – or experiencing less than normal oxygen blood levels – was associated with worsened survival.
Brain image highlighting areas
Health Lab
Women stroke survivors believe they will receive worse care in the emergency room
National study examined health care perceptions of approximately 3,500 women, including those with and without a history of stroke